Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $167,535 - $205,326
5,100 Added 5.92%
91,200 $3.46 Million
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $565,364 - $749,060
-17,200 Reduced 16.65%
86,100 $2.88 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $1.75 Million - $2.02 Million
-46,200 Reduced 30.9%
103,300 $4.42 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $2.01 Million - $2.47 Million
63,300 Added 73.43%
149,500 $5.78 Million
Q3 2023

Nov 15, 2023

BUY
$37.32 - $49.29 $1.15 Million - $1.52 Million
30,800 Added 55.6%
86,200 $3.25 Million
Q2 2023

Aug 23, 2023

SELL
$39.98 - $47.68 $7.55 Million - $9.01 Million
-188,900 Reduced 77.32%
55,400 $2.52 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $6.47 Million - $9.05 Million
172,200 Added 238.83%
244,300 $9.85 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $1.76 Million - $2.04 Million
35,400 Added 96.46%
72,100 $3.68 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $220,826 - $273,880
4,100 Added 12.58%
36,700 $2.03 Million
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $1.16 Million - $1.46 Million
18,200 Added 126.39%
32,600 $2.15 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $1.11 Million - $1.29 Million
14,400 New
14,400 $1.14 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $3.72 Million - $4.35 Million
-49,900 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $3.68 Million - $4.17 Million
49,900 New
49,900 $4.08 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.